Search research articles
Contact Us
Filters
Showing results (91-100 of 99) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 99 results.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
February 9, 2008
Non-pharmacological control of plasma cholesterol levels
Andrea Poli, Franca Marangoni, Rodolfo Paoletti, et al.
Giornale Italiano Di Cardiologia (2006)
|
September 28, 2023
[How to overcome barriers to implementation of prevention and management strategies of atherosclerotic cardiovascular disease through lipid-lowering therapy]
Marcello Arca, Maurizio Averna, Claudio Borghi, et al.
Journal of Neurology
|
February 1, 2018
A common CHRNE mutation in Brazilian patients with congenital myasthenic syndrome
Eduardo de Paula Estephan, Cláudia Ferreira da Rosa Sobreira, André Clériston José Dos Santos, et al.
Journal of the American College of Cardiology
|
January 20, 2018
Autosomal Recessive Hypercholesterolemia: Long-Term Cardiovascular Outcomes
Laura D'Erasmo, Ilenia Minicocci, Antonio Nicolucci, et al.
Cardiovascular Diabetology
|
January 28, 2014
Residual macrovascular risk in 2013: what have we learned?
Jean-Charles Fruchart, Jean Davignon, Michel P Hermans, et al.
Annals of Clinical and Translational Neurology
|
March 19, 2026
Onasemnogene Abeparvovec in Type I Spinal Muscular Atrophy: 24-Month Follow-Up From the Italian Registry
Marika Pane, Giorgia Coratti, Chiara Cutrì, et al.
Annals of Neurology
|
May 10, 2019
A multicenter retrospective study of charcot-marie-tooth disease type 4B (CMT4B) associated with mutations in myotubularin-related proteins (MTMRs)
Davide Pareyson, Tanya Stojkovic, Mary M Reilly, et al.
Molecular Genetics and Metabolism
|
July 4, 2024
Developmental delay can precede neurologic regression in early onset metachromatic leukodystrophy
Laura Ann Adang, Samuel Groeschel, Chloe Grzyb, et al.
Cardiovascular Diabetology
|
June 6, 2019
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation
Jean-Charles Fruchart, Raul D Santos, Carlos Aguilar-Salinas, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 99) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 99 results.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
February 9, 2008
Non-pharmacological control of plasma cholesterol levels
Andrea Poli, Franca Marangoni, Rodolfo Paoletti, et al.
Giornale Italiano Di Cardiologia (2006)
|
September 28, 2023
[How to overcome barriers to implementation of prevention and management strategies of atherosclerotic cardiovascular disease through lipid-lowering therapy]
Marcello Arca, Maurizio Averna, Claudio Borghi, et al.
Journal of Neurology
|
February 1, 2018
A common CHRNE mutation in Brazilian patients with congenital myasthenic syndrome
Eduardo de Paula Estephan, Cláudia Ferreira da Rosa Sobreira, André Clériston José Dos Santos, et al.
Journal of the American College of Cardiology
|
January 20, 2018
Autosomal Recessive Hypercholesterolemia: Long-Term Cardiovascular Outcomes
Laura D'Erasmo, Ilenia Minicocci, Antonio Nicolucci, et al.
Cardiovascular Diabetology
|
January 28, 2014
Residual macrovascular risk in 2013: what have we learned?
Jean-Charles Fruchart, Jean Davignon, Michel P Hermans, et al.
Annals of Clinical and Translational Neurology
|
March 19, 2026
Onasemnogene Abeparvovec in Type I Spinal Muscular Atrophy: 24-Month Follow-Up From the Italian Registry
Marika Pane, Giorgia Coratti, Chiara Cutrì, et al.
Annals of Neurology
|
May 10, 2019
A multicenter retrospective study of charcot-marie-tooth disease type 4B (CMT4B) associated with mutations in myotubularin-related proteins (MTMRs)
Davide Pareyson, Tanya Stojkovic, Mary M Reilly, et al.
Molecular Genetics and Metabolism
|
July 4, 2024
Developmental delay can precede neurologic regression in early onset metachromatic leukodystrophy
Laura Ann Adang, Samuel Groeschel, Chloe Grzyb, et al.
Cardiovascular Diabetology
|
June 6, 2019
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation
Jean-Charles Fruchart, Raul D Santos, Carlos Aguilar-Salinas, et al.
Page
of 10